Total Funding
6
Total FundingSeries A raised
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
171923
Non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.
Clayton D. Knox: COOPast Role: AcertaPharma, SVP, Corporate Development and Strategy
About the Company
Mavupharma is developing non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.
